Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Clinical trial NCT06892093 · RECRUITING

Trial details

NCT number: NCT06892093
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Diarrhea Caused by Drug Neratinib

Start date: 2025-08-07
Primary completion: 2027-06-01
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.